Passage Bio Inc (PASG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 8,655 | 10,334 | 16,459 | 14,270 | 20,702 |
| Operating Income | -8,655 | -10,334 | -16,459 | -14,270 | -20,702 |
| Other Income | 906 | 949 | 1,054 | 1,545 | 1,362 |
| Pre-tax Income | -7,749 | -9,385 | -15,405 | -12,725 | -19,340 |
| Net Income Continuous | -7,749 | -9,385 | -15,405 | -12,725 | -19,340 |
| Net Income | $-7,749 | $-9,385 | $-15,405 | $-12,725 | $-19,340 |
| EPS Basic Total Ops | -2.44 | -2.96 | -5.00 | -4.16 | -6.15 |
| EPS Basic Continuous Ops | -2.44 | -2.96 | -4.96 | -4.27 | -6.15 |
| EPS Diluted Total Ops | -2.44 | -2.96 | -5.00 | -4.16 | -6.15 |
| EPS Diluted Continuous Ops | -2.44 | -2.96 | -4.96 | -4.27 | -6.15 |
| EPS Diluted Before Non-Recurring Items | -2.44 | -2.96 | -5.00 | -4.00 | -6.20 |
| EBITDA(a) | $-8,474 | $-10,165 | $-16,129 | $-13,916 | $-20,364 |